Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1249449.RAokKuXr1xLmjaUXj09f5PJOU4Tg5DLy-tuAfZAQH65rI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1249449.RAokKuXr1xLmjaUXj09f5PJOU4Tg5DLy-tuAfZAQH65rI130_assertion type Assertion NP1249449.RAokKuXr1xLmjaUXj09f5PJOU4Tg5DLy-tuAfZAQH65rI130_head.
- NP1249449.RAokKuXr1xLmjaUXj09f5PJOU4Tg5DLy-tuAfZAQH65rI130_assertion description "[PRLR(I146L) is the first identified gain-of-function variant of the prolactin receptor (PRLR) that was proposed to be associated with benign breast tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249449.RAokKuXr1xLmjaUXj09f5PJOU4Tg5DLy-tuAfZAQH65rI130_provenance.
- NP1249449.RAokKuXr1xLmjaUXj09f5PJOU4Tg5DLy-tuAfZAQH65rI130_assertion evidence source_evidence_literature NP1249449.RAokKuXr1xLmjaUXj09f5PJOU4Tg5DLy-tuAfZAQH65rI130_provenance.
- NP1249449.RAokKuXr1xLmjaUXj09f5PJOU4Tg5DLy-tuAfZAQH65rI130_assertion SIO_000772 25524456 NP1249449.RAokKuXr1xLmjaUXj09f5PJOU4Tg5DLy-tuAfZAQH65rI130_provenance.
- NP1249449.RAokKuXr1xLmjaUXj09f5PJOU4Tg5DLy-tuAfZAQH65rI130_assertion wasDerivedFrom befree-2016 NP1249449.RAokKuXr1xLmjaUXj09f5PJOU4Tg5DLy-tuAfZAQH65rI130_provenance.
- NP1249449.RAokKuXr1xLmjaUXj09f5PJOU4Tg5DLy-tuAfZAQH65rI130_assertion wasGeneratedBy ECO_0000203 NP1249449.RAokKuXr1xLmjaUXj09f5PJOU4Tg5DLy-tuAfZAQH65rI130_provenance.